Omics Archive leverages AI and blockchain to revolutionize sustainable biotechnology, offering a platform for federated learning, data licensing, and the trading of microbial omics data to accelerate synthetic biology innovations.
Omics Archive is a biotechnology company that integrates artificial intelligence, blockchain, and synthetic biology to advance sustainable biomanufacturing. The company provides a platform that utilizes federated learning to allow AI developers to train models on proprietary and in-house omics and digital sequence datasets while maintaining data privacy. By leveraging blockchain technology, the platform enables the conversion of omics data and digital sequences into tradable assets, supporting a marketplace for data licensing, generation funding, and trading stakes in datasets.
This integrated approach aims to accelerate data-driven discoveries and innovations in the biotechnology sector. The platform offers services that support the decentralized management of data assets and the operational needs of autonomous biomanufacturing plants. By providing tools for researchers and businesses to navigate microbial omics data, Omics Archive seeks to enhance the velocity and marketability of synthetic biology initiatives, facilitating more efficient research and development cycles for biotech start-ups.